Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002) – The Lancet Invited commentary: Longer intervals and extra doses of ChAdOx1 nCoV-19 vaccine   Commentaries on Twitter (thread – click for more) Substudy suggests extended interval […]

The post Extended intervals and extra doses of the AstraZeneca vaccine are associated with increased immunogenicity. appeared first on Links Medicus.